7 Results for "

gastric mucosal protection

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "gastric mucosal protection" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-B0360
CAS No.: 90098-04-7
Synonyms: OPC12759; Proamipide
Target:  

COX

Research Areas:  

Inflammation/Immunology Cancer

Rebamipide (OPC12759) is an orally active gastroprotective agent that enhances the production of endogenous PGs (especially intragastric PGE2) by inducing COX-2 expression, thereby protecting the gastric mucosa from injury. Rebamipide exerts anti-proliferative activity against gastric cancer cells. Rebamipide can be used in studies of mucosal protection, gastroduodenal ulcer, gastritis and gastric cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-125556
CAS No.: 1947-37-1
Purity:  99.60%
Synonyms: Cholecystokinin tetrapeptide; CCK-4
Research Areas:  

Metabolic Disease

Tetragastrin (Cholecystokinin tetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin. Tetragastrin can stimulate gastric secretion . Tetragastrin is a Cholecystokinin (CCK-4) receptor agonist . Gastric mucosal protection .
loading...
    loading...
Cat. No.: HY-165131
CAS No.: 7212-91-1
Synonyms: Delta-7-avenasterol
Research Areas:  

Inflammation/Immunology

Δ7-Avenasterol (Delta-7-avenasterol) is a phytosterol that binds to prostaglandin E2 receptor (prostaglandin E2 receptor) and cyclooxygenase-2 (COX-2). Δ7-Avenasterol is applicable to research related to gastric ulcer, anti-inflammation and antioxidation .
loading...
    loading...
Cat. No.: HY-15538
CAS No.: 100981-43-9
Purity:  98.51%
Synonyms: FI3542
Ebrotidine (FI3542) is a competitive histamine H2 receptor (histamine H2 receptor) antagonist with gastric acid secretion inhibitory and gastric mucosal protective effects. Ebrotidine alleviates gastric mucosal injury and epithelial cell apoptosis induced by Indomethacin (HY-14397) and Helicobacter pylori LPS (HY-D1056), and accelerates chronic gastric ulcer healing by promoting rapid recovery of IL-4 and inhibiting TNF-α, endothelin-1 (ET-1) and NOS-2. Ebrotidine can be used in studies on gastric ulcer healing, NSAID-induced gastric mucosal injury, Helicobacter pylori-associated gastritis, and H2 receptor-mediated gastric mucosal protection mechanisms .
loading...
    loading...
Cat. No.: HY-B0360R
CAS No.: 90098-04-7
Target:  

COX Reference Standards

Research Areas:  

Inflammation/Immunology Cancer

Rebamipide (Standard) is the analytical standard of Rebamipide. This product is intended for research and analytical applications. Rebamipide (OPC12759) is an orally active gastroprotective agent that enhances the production of endogenous PGs (especially intragastric PGE2) by inducing COX-2 expression, thereby protecting the gastric mucosa from injury. Rebamipide exerts anti-proliferative activity against gastric cancer cells. Rebamipide can be used in studies of mucosal protection, gastroduodenal ulcer, gastritis and gastric cancer .
loading...
    loading...
Cat. No.: HY-105126
CAS No.: 77287-05-9
Synonyms: TR4698
Research Areas:  

Others

Rioprostil (TR4698) is an orally effective analogue of prostaglandin E1, possessing potent antisecretory and anti-gastric lesion properties. Rioprostil can be utilized in mucosal protection research .
loading...
    loading...
Cat. No.: HY-15538R
CAS No.: 100981-43-9
Synonyms: FI3542 (Standard)
Ebrotidine (Standard) (FI3542 (Standard)) is the analytical standard of Ebrotidine (HY-15538). This product is intended for research and analytical applications. Ebrotidine (FI3542) is a competitive histamine H2 receptor (histamine H2 receptor) antagonist with gastric acid secretion inhibitory and gastric mucosal protective effects. Ebrotidine alleviates gastric mucosal injury and epithelial cell apoptosis induced by Indomethacin (HY-14397) and Helicobacter pylori LPS (HY-D1056), and accelerates chronic gastric ulcer healing by promoting rapid recovery of IL-4 and inhibiting TNF-α, endothelin-1 (ET-1) and NOS-2. Ebrotidine can be used in studies on gastric ulcer healing, NSAID-induced gastric mucosal injury, Helicobacter pylori-associated gastritis, and H2 receptor-mediated gastric mucosal protection mechanisms .
loading...
    loading...